Literature DB >> 34293483

SARS-CoV-2 as a betacoronavirus comprises five structural proteins?

Milad Zandi1, Saber Soltani2, Kambiz Feyzi3.   

Abstract

Entities:  

Year:  2021        PMID: 34293483      PMCID: PMC8289725          DOI: 10.1016/j.meegid.2021.105011

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


× No keyword cloud information.
Dear editor, We read with interest a review article by Bakhshandeh et al. (Bakhshandeh et al., 2021). The authors considered hemagglutinin esterase (HE) as one of the structural proteins of SARS-CoV-2 (Bakhshandeh et al., 2021). Although, scientific evidences show that the genome of SARS-CoV-2 lacks the HE gene and it has no hemagglutinin-esterase glycoprotein (Kumar et al., 2020; Anastasopoulou and Mouzaki, 2020; Crawford et al., 2020; Zhang et al., 2020). Thus, HE cannot be considered as an antigenic component in SARS-CoV-2 and it has no role in SARS-CoV-2 infection. SARS-CoV-2 as a betacoronavirus contains a non-segmented positive-sense, single-stranded RNA (Pal et al., 2020). The genome of SARS-CoV-2 has been sequenced, and based on the genomic sequence, SARS-CoV-2 shared 79.6% sequence identity to SARS-CoV and 96% identity similar to bat coronavirus (Zhou et al., 2020). The genome organization of SARS-CoV-2 is 5’UTR-Rep-S-3a-3b-E-M-6-7a-7b-8-N-10-3’UTR (Abdel-Moneim and Abdelwhab, 2020). Coronaviruses comprise four structural proteins spike (S), envelope (E), membrane protein (M), and nucleoprotein (N) (Fani et al., 2021), however, some betacoronaviruses such as OC43-CoV, Bovine-CoV and HKU1-CoV and, murine hepatitis virus encode hemagglutinin esterase (Lang et al., 2020). Therefore SARS-CoV-2 lacks HE and comprises four structural proteins S, E, M and N.

Declaration of competing interest

The authors declare that there is no conflict of interest for this manuscript entitle “SARS-CoV-2 as a betacoronavirus comprises five structural proteins?”
  1 in total

1.  Role of hemagglutinin esterase protein in neurological manifestation of COVID-19.

Authors:  Milad Zandi; Hassan Karami; Saber Soltani
Journal:  Fluids Barriers CNS       Date:  2021-08-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.